Published in Cancer Res on July 01, 1986
Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts. Neoplasia (2001) 1.56
Inhibition of angiogenesis and tumor growth in the brain. Suppression of endothelial cell turnover by penicillamine and the depletion of copper, an angiogenic cofactor. Am J Pathol (1990) 1.29
Applications of magnetic resonance in model systems: tumor biology and physiology. Neoplasia (2000) 1.25
Estimations of intra- and extracellular volume and pH by 31P magnetic resonance spectroscopy: effect of therapy on RIF-1 tumours. Br J Cancer (1998) 1.02
Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines. Bioimpacts (2014) 0.86
The effect of adrenalectomy and dexamethasone on interleukin-1 alpha induced responses in RIF-1 tumours. Br J Cancer (1990) 0.75
Aromatic amino acids and modification of parkinsonism. N Engl J Med (1967) 5.46
NMR study of in vivo RIF-1 tumors. Analysis of perchloric acid extracts and identification of 1H, 31P and 13C resonances. Biochim Biophys Acta (1984) 1.31
Studies on lymphopoiesis. VII. Size distribution of bovine thoracic duct lymphocytes. Proc Soc Exp Biol Med (1966) 1.13
Cytokinetics of the S-180 ascites tumor system. Cell Tissue Kinet (1973) 0.91
The cell kinetics of human mammary cancers. Cancer (1979) 0.88
Proliferative defects in renal and intestinal epithelium after cis-dichlorodiammine platinum (II). Br J Cancer (1982) 0.88
Autoradiographic detection of DNA polymerase containing nuclei in sarcoma 180 ascites cells. Cell Tissue Kinet (1973) 0.87
1H-NMR relaxation times and water compartmentalization in experimental tumor models. Magn Reson Imaging (1986) 0.86
In vitro labeling and gold activation autoradiography for determination of labeling index and DNA synthesis times of solid tumors. Cancer Res (1976) 0.86
Human lymphocyte proliferation: DNA synthesis time. Cell Tissue Kinet (1971) 0.86
Nitric oxide and neopterin levels and clinical response in stage III melanoma patients receiving concurrent biochemotherapy. Melanoma Res (1998) 0.85
Effect of methylprednisolone on cell proliferation in C3H/HeJ spontaneous mammary tumors. Cancer Res (1978) 0.85
Lymphocyte kinetics in chronic lymphocytic leukaemia (CLL) studied by ECIB. Br J Haematol (1969) 0.84
Tumor bioenergetics and blood flow in RIF-1 murine tumors treated with 5-fluorouracil. Magn Reson Med (1991) 0.84
The maturation and fate of reticulocytes after in vitro labeling with tritiated amino acids. Blood (1968) 0.83
Attempts at isolation of lymphocytosis-producing factor from supernatant fluids of Bordetella pertussis cultures. Proc Soc Exp Biol Med (1970) 0.82
Adriamycin-induced delayed erythropoietic injury expressed following anemia stress. Cancer Res (1980) 0.82
31P-nuclear magnetic resonance studies of the effect of recombinant human interleukin 1 alpha on the bioenergetics of RIF-1 tumors. Cancer Res (1989) 0.82
Cell kinetic analysis of a human melanoma in vitro and in vivo-vitro. J Natl Cancer Inst (1971) 0.82
Studies on lymphocytes. X. Influence of extracorporeal irradiation of the blood on lymphocytes in chronic lymphocytic leukemia: apparent correlation with RNA turnover. Radiat Res (1969) 0.81
The generation time of human leukemic myeloblasts. Lab Invest (1972) 0.81
Extracorporeal irradiation of the blood. Semin Hematol (1966) 0.81
Leukocyte kinetics in chronic myeloid leukemia. I. DNA synthesis time in blood and marrow myelocytes. Blood (1969) 0.80
Effect of adriamycin on the cell kinetics of 13762 rat mammary tumors and implications for therapy. Cancer Treat Rep (1980) 0.80
Studies on lymphocytes. IX. The survival of atuotransfused labeled lymphocytes in chronic lymphocytic leukemia. Eur J Cancer (1968) 0.79
Fluorine nuclear magnetic resonance: calibration and system optimization. Magn Reson Imaging (1985) 0.79
Modification of skin allograft immunity by extracorporeal irradiation of lymph. Transplantation (1967) 0.79
Anemic stress as a trigger of myelogenous leukemia in the unirradiated RF mouse. Science (1972) 0.78
Acute hemorrhagic necrosis of tumors induced by interleukin-1 alpha: effects independent of tumor necrosis factor. J Natl Cancer Inst (1991) 0.78
Separation of lymphocytes from blood of calves and goats. Am J Vet Res (1969) 0.78
Menstrual variation of normal breast NMR relaxation parameters. J Comput Assist Tomogr (1985) 0.78
Therapeutic implications of cell kinetic changes after cyclophosphamide treatment in "spontaneous" and "transplantable" mammary tumors. Cancer Treat Rep (1978) 0.77
Targeting nitric oxide to cancer cells: cytotoxicity studies of glyco-S-nitrosothiols. Bioorg Med Chem Lett (1999) 0.77
Human colonic tumor cell kinetics: potential for therapy. Cancer (1977) 0.77
Extracorporeal irradiation of blood in man: radiation resistance of circulating platelets. Radiat Res (1968) 0.77
The cytokinetic basis for the design of efficacious radiotherapy protocols. Int J Radiat Oncol Biol Phys (1979) 0.76
Cell kinetic-directed sequential chemotherapy with cyclophosphamide and adriamycin in T1699 mammary tumors. Cancer Res (1980) 0.76
Role of corticosteroid hormones in the control of cell proliferation in residual tumor after surgical cytoreduction. Cancer Res (1983) 0.76
Receptor-dependent antiproliferative effects of corticosteroids in radiation-induced fibrosarcomas and implications for sequential therapy. Cancer Res (1982) 0.76
Renal and haemopoietic proliferative defects as a delayed consequence of cis-platin, adriamycin and daunomycin treatments. Br J Cancer (1982) 0.75
Treatment of six cases of mesothelioma with doxorubicin and cisplatin. Cancer (1983) 0.75
Receptor-mediated antiproliferative effects of corticosteroids in Lewis lung tumors. Eur J Cancer Clin Oncol (1984) 0.75
Skin allograft survival in lymphocyte-depleted calves. Transplant Proc (1969) 0.75
Cytotoxic antibody response to skin allografts in calves: effects of exttracorporeal irradiation of lymph. Proc Soc Exp Biol Med (1968) 0.75
Dose determination in high dose-rate brachytherapy. Int J Radiat Oncol Biol Phys (1992) 0.75
Tritiated thymidine as a cytocidal agent in human leukemia. Blood (1966) 0.75
Iron absorption and excretion in aregenerative anaemia. A collaborative Swedish-American whole body counter study. Acta Haematol (1966) 0.75
Cell kinetic alterations in murine mammary tumors following fasting and refeeding. Eur J Cancer (1979) 0.75
Tumor cell population kinetics following noncurative treatment. Antibiot Chemother (1971) (1978) 0.75
Experience with arteriovenous shunts in leukemic patients. Arch Surg (1968) 0.75
Biological implications of androgen dependent changes in proton-NMR relaxation times in rat ventral prostate. Prostate (1986) 0.75
Cell kinetics of human breast cancer and relationship to animal models. Bull Cancer (1978) 0.75
Cell kinetics after vincristine treatment of C3H/He spontaneous mammary tumors: implications for therapy. J Natl Cancer Inst (1978) 0.75
Correlation between glucocorticoid receptor content and the antiproliferative effect of dexamethasone in experimental solid tumors. Cancer Res (1983) 0.75
DNA-dependent-DNA-polymerase: possible limiting influence on cell reproduction during viral leukemogenesis. Experientia (1978) 0.75
Invited discussion: Proliferation of cells in Hodgkin's disease. Natl Cancer Inst Monogr (1973) 0.75
Effect of methylprednisolone on the cell kinetic response of C3H/HeJ mammary tumors to cyclophosphamide and adriamycin. Cancer Res (1979) 0.75
[Extracorporeal radiation of the blood in chronic lymphocytic leukemia]. Nouv Rev Fr Hematol (1969) 0.75
Effects of extracorporeal irradiation of the blood on leukemia: malignant lymphoma of cattle. Am J Vet Res (1967) 0.75
Cycling characteristics of human lymphocytes in vitro. Blood (1974) 0.75
Cell kinetics in vivo and in vitro for C3H/He spontaneous mammary tumors. J Natl Cancer Inst (1977) 0.75
A procedure for the application of cell kinetic techniques to human tumor samples. Eur J Cancer (1980) 0.75
Extracorporeal irradiation of the blood in humans: effects upon erythrocyte survival. Blood (1966) 0.75
Studies on lymphocytes. XII. The role of immunologically committed lymphocytes in rejecting skin allografts. Transplantation (1969) 0.75
Estimation of tumor growth fraction in murine tumors by the primer-available DNA-dependent DNA polymerase assay. Cancer Res (1976) 0.75
Rapid methods for utilizing cell kintics for treatment in the C3H/He spontaneous mammary tumor: effects of vincristine. Cancer Treat Rep (1976) 0.75
In vivo effects of recombinant human and murine interleukin-1 alpha (IL-1 alpha) on murine hematopoiesis. In Vivo (1991) 0.75
Extracorporeal irradiation of blood (ECIB) in man. II. Treatment of acute myelocytic leukemia. Blood (1968) 0.75
Erythropoietic and reticuloendothelial function in bone marrow in dogs. Science (1966) 0.75
Growth kinetics of mammary tumor 13762 in rats previously cured by chemotherapy. J Natl Cancer Inst (1980) 0.75
Preliminary observations on the correlation of proliferative phenomena with in vivo 31P NMR spectroscopy after tumor chemotherapy. Ann N Y Acad Sci (1985) 0.75
Kinetically directed combination therapy with adriamycin and x-irradiation in a mammary tumor model. Int J Radiat Oncol Biol Phys (1981) 0.75
Antiproliferative effects of corticosteroids in C3H/HeJ Mammary tumors and implications for sequential combination chemotherapy. Cancer Res (1981) 0.75
Skin allograft survival in calves. Influence of thymectomy and extracorporeal irradiation of blood. Arch Surg (1969) 0.75
Body retention of hydroxocobalamin and cyanocobalamin. BNL 6942. Tech Rep Brookhaven Natl Lab (1965) 0.75
Whole-body counting studies of retention and accessibility of radioactive vitamin B 12. Am J Clin Nutr (1968) 0.75
Kinetic analysis of splenic erythropoiesis in mice under prolonged hypoxic stress. Exp Hematol (1973) 0.75
Observations on the in-vitro measurement of human lymphocyte DNA synthesis time. Cell Tissue Kinet (1971) 0.75
In vivo plasma binding capacity for cyanocobalamin. Br J Haematol (1966) 0.75
Cytokinetic stability of an Ehrlich ascites tumor. Cell Tissue Kinet (1974) 0.75
Nuclear DNA polymerase-alpha and replicative potential in mammalian cells. Eur J Cancer (1977) 0.75